Cullinan Therapeutics, Inc. (CGEM)
NASDAQ · Healthcare
Cullinan Therapeutics, Inc. Net Income 2020–2022
Cullinan Therapeutics, Inc. annual/quarterly net income history and growth rate from 2020 to 2022. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Cullinan Therapeutics, Inc. net income for the quarter ending September 30, 2022 was -24.8 M, a 42.96% increase year-over-year.
- Cullinan Therapeutics, Inc. net income for the twelve months ending September 30, 2022 was 120.6 M.
- Cullinan Therapeutics, Inc. annual net income for 2022 was 111.2 M, a 269.61% decrease from 2021.
- Cullinan Therapeutics, Inc. annual net income for 2021 was -65.6 M, a 26.59% increase from 2020.
- Cullinan Therapeutics, Inc. annual net income for 2020 was -51.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cullinan Therapeutics, Inc. Net Income — FAQ
Cullinan Therapeutics, Inc. (CGEM) net income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Cullinan Therapeutics, Inc.'s net income?
Cullinan Therapeutics, Inc. (CGEM) reported net income of $111M for fiscal 2022.
Where can I see CGEM's net income history?
The chart and table above show Cullinan Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.